Nuclear delivery of oligonucleotides via nanocomposites based on TiO2 nanoparticles and polylysine
- Authors: Chelobanov B.P.1,2, Repkova M.N.1,2, Baiborodin S.I.3, Ryabchikova E.I.1,2, Stetsenko D.A.1
-
Affiliations:
- Institute of Chemical Biology and Fundamental Medicine
- Novosibirsk State University
- Institute of Cytology and Genetics
- Issue: Vol 51, No 5 (2017)
- Pages: 695-704
- Section: Molecular Cell Biology
- URL: https://journals.rcsi.science/0026-8933/article/view/163230
- DOI: https://doi.org/10.1134/S0026893317050065
- ID: 163230
Cite item
Abstract
The nuclear delivery of nucleic acid derivatives is an essential prerequisite for successful antisense therapy. Using laser confocal and electron microscopy, we have studied the uptake of fluorescently labeled oligonucleotides in the form of nanocomposites with polylysine and TiO2 nanoparticles into Caco2, MDCK, and HeLa cells. In all three cell lines, bright fluorescence has been detected after 30 min in the nuclei (excluding the nucleoli) of the interphase cells; no substantial increase in the intensity of the signal was observed for next 24 hours. In all cells undergoing mitosis, the signal was localized in the cytoplasm with zones of higher intensity around chromatin. In some cells, at the beginning of interphase (G-1 phase), fluorescence was not detected at all. The latter may be explained by the brief moment in the cell cycle when oligonucleotides delivered in the nanocomposite cannot be taken up by cells. The studied nanocomposites are prone to aggregation. The degree of aggregation increases with the storage time up to complete loss of the ability of the nanocomposites to penetrate the cells.
About the authors
B. P. Chelobanov
Institute of Chemical Biology and Fundamental Medicine; Novosibirsk State University
Author for correspondence.
Email: boris.p.chelobanov@gmail.com
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090
M. N. Repkova
Institute of Chemical Biology and Fundamental Medicine; Novosibirsk State University
Email: boris.p.chelobanov@gmail.com
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090
S. I. Baiborodin
Institute of Cytology and Genetics
Email: boris.p.chelobanov@gmail.com
Russian Federation, Novosibirsk, 630090
E. I. Ryabchikova
Institute of Chemical Biology and Fundamental Medicine; Novosibirsk State University
Email: boris.p.chelobanov@gmail.com
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090
D. A. Stetsenko
Institute of Chemical Biology and Fundamental Medicine
Email: boris.p.chelobanov@gmail.com
Russian Federation, Novosibirsk, 630090
Supplementary files
